GAL and Chagas disease: Indeed, the α3GalT1 KO mouse, initially developed for xenotransplantation rejection research [42,43], has subsequently been utilized—due to the unique immunological characteristics of the αGal epitope and anti-Gal antibodies—in studies spanning anti-tumor immunity [44] and experimental Chagas disease models [45].